Stivarga 40mg Regorafenib Tablets

Link Copied
75,000.00 / Box

100 Box (MOQ)

Business Type Exporter, Supplier, Trader
Packaging Size 28 Tablets
Packaging Type Box
Manu8facturer Bayer
Click to view more

Product Details

Brand Name
Stivargo
Country of Origin
Made in India
Form
Tablets
Application
Oral Multi-kinase Inhibitor Targeting Angiogenic, Stromal, And Oncogenic Receptor Tyrosine Kinase
Dosage
40mg

Product Description

  • Regorafenib is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase. Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition

Yes! I am interested

Looking for "Stivarga 40mg Regorafenib Tablets" ?

Box

Explore More Products

Our Blogs



Close

Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

WhatsApp Us